To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults
Clinical trial NCT04885361 · UNKNOWN
Trial details
- NCT number
- NCT04885361
- Sponsor
- OSE Immunotherapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2021-09-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.